PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Conditions: Esophageal Neoplasms Interventions: Radiation: Radiation; Drug: TP or PF regimen depended on investigator ' s choice.; Biological: PD-1 inhibitor Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University Cancer Hospital& Institute; Beijing Cancer Prevention& Treatment Society; Hebei Medical University Fourth Hospital; Tianjin Medical University Cancer Institute and Hospital; Fujian Cancer Hospital; Anyang Tumor Hospital; The First Affiliated Hospital with Nanjing Medical University; Sichuan Cancer Hospital and Research Institute; Tengzhou Central People ' s Hospital; The First Affiliated Hospital of Xiamen University; The First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital Xi ' an Jiaotong University; Second Affiliated Hospital of Xi ' an Jiaotong University; Af filiated Hospital of North Sichuan Medical College; Changzhou Cancer Hospital of Soochow University; Henan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials